5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Myeloid Leukemia: new trials by email Literature Review of Myeloid Leukemia trials Research Report on Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients Intravenous (IV) and oral Vitamin C - Lymphoid Leukemia, Myeloid Leukemia | Phase 2 | Completed | Virginia Commonwealth University | 61 | 2018-10-01 | 2023-11-07 |
| NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents cyclophosphamide, Fludarabine, NK cell infusion - Acute Myeloid Leukemia, Leukemia | Phase 2 | Completed | Instituto de Investigación Hospital Universitario La Paz | 7 | 2016-05-01 | 2020-10-05 |
| Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies Fludarabine phosphate, Busulfan, Total-Body Irradiation - Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 62 | 2012-12-24 | 2025-10-30 |
| Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) filgrastim, pegfilgrastim - Myeloid Leukemia | Phase 2 | Completed | Amgen | 84 | 2003-03-01 | 2008-10-31 |
| Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults Blood cell transplantation - Chronic Lymphocytic Leukemia, Graft vs Host Disease | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 28 | 1997-09-29 | 2019-12-17 |
Leukemia, Myeloid (5) · Leukemia, Myeloid, Acute (4) · Graft vs Host Disease (2) · Leukemia (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Myelodysplastic Syndromes (2) · Anemia, Aplastic (1) · Anemia, Refractory, with Excess of Blasts (1) · Hodgkin Disease (1) · Leukemia, Lymphoid (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Prolymphocytic (1) · Lymphoma, Follicular (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Bone Marrow Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Anemia (2) · Chronic Disease (2) · Disease Attributes (2) · Leukemia, B-Cell (2) · Leukemia, Lymphoid (2)
Cyclophosphamide (2) · Ascorbic Acid (1) · Busulfan (1) · Filgrastim (1) · Interleukin-2 (1) · Mycophenolic Acid (1) · Peripheral Blood Stem Cell Transplantation (1) · Stem Cell Transplantation (1) · Tacrolimus (1) · Whole-Body Irradiation (1) · aldesleukin (1) · fludarabine (1) · fludarabine phosphate (1) · methanesulfonic acid (1) · pegfilgrastim (1)
Amgen (1) · Instituto de Investigación Hospital Universitario La Paz (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Virginia Commonwealth University (1)
United States (3) · Spain (1)
A. John Barrett, M.D. (1) · Dolores Grosso, RN, CRNP, DNP (1) · Neal Flomenberg, MD (1) · William B Clark, MD (1)
PMID 18616811, PMID 31919123, PMID 33610500
2015 (1)